Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.
Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check15 days agoChange DetectedThe webpage has been updated to include new clinical trial identifiers, additional cancer types, and a revised timeline for patient treatment assignments, while removing extensive details about the trial's objectives and treatment protocols.SummaryDifference31%
- Check27 days agoChange DetectedThe webpage has been updated to include new results and metrics related to cancer treatment outcomes, such as progression-free survival (PFS), overall survival (OS), and quality of life (QoL) assessments, while removing outdated information and previous result dates.SummaryDifference13%
- Check139 days agoChange DetectedDifference0.4%
- Check146 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check153 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.SummaryDifference0.7%
- Check162 days agoChange DetectedThe website has been updated from version 2.12.1 to 2.12.2.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.